Nicholas A Saccomano's Net Worth
$11.1 Million
Who is Nicholas A Saccomano?
Nicholas A Saccomano has an estimated net worth of $11.1 Million. This is based on reported shares in ARRAY BIOPHARMA INC.
SEC CIK
Nicholas A Saccomano's CIK is 0001609284
Past Insider Trading and Trends
2018 was Nicholas A Saccomano's most active year for acquiring shares with 5 total transactions. Nicholas A Saccomano's most active month to acquire stocks was the month of November. 2019 was Nicholas A Saccomano's most active year for disposing of shares, totalling 15 transactions. Nicholas A Saccomano's most active month to dispose stocks was the month of March. 2019 saw Nicholas A Saccomano paying a total of $1,087,500.00 for 296,250 shares, this is the most they've acquired in one year. In 2019 Nicholas A Saccomano cashed out on 1,407,740 shares for a total of $11,799,661.91, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ARRAY BIOPHARMA INC No price found
CSO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -212.00K |
$48.00 |
—
|
0
|
Jul 30
| |||
Form 4
| +5.41% | 7.7K |
$24.60 | -$148,780.80 | 150.19K |
Apr 1
| |||
Form 4
|
—
|
0
|
$12.63 | -$3,354,247.56 | 142.49K |
Scheduled
|
Feb 7
| ||
Form 4
| +107.48% | 73.81K |
$11.44 | -$13.55 | 142.49K |
Jan 31
| |||
Form 4
| +11.32% | 6.98K |
$15.97 | -$87,595.45 | 68.68K |
Dec 14 - Dec 16
| |||
Form 4
| +11.60% | 6.42K |
$18.50 | -$93,203.00 | 61.69K |
Jun 27
| |||
Form 4
| +1.39% | 757 |
$16.32 | -$99,845.76 | 55.28K |
Apr 1
| |||
Form 4
| +5.66% | 2.92K |
$10.92 | -$27,824.16 | 54.52K |
Dec 16
| |||
Form 4/A
| -14.74% | -6.54K |
$8.94 | -$58,494.42 | 37.85K |
Apr 1
| |||
Form 4
| +6.65% | 2.34K |
$8.94 | -$40,542.90 | 37.53K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 27
| |||
Form 4
| -6.79% | -2.56K |
$3.00 | -$7,692.00 | 35.19K |
Apr 1
| |||
Form 4
| +331.33% | 27.5K |
—
|
—
| 35.8K |
Apr 1
| |||
Form 4
|
∞
| 7.42K |
$7.96 | $59,063.20 | 7.42K |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OnKure Therapeutics, Inc. (OKUR) No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||